Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Maarten J H I Beekman"'
Autor:
David Hsien Yung Tan, Tze Lee Tan, Wee Hian Tan, Cheryl Choong, Maarten J H I Beekman, Joanne Huiyi Khor, S Suraj Kumar, Geraldine Ruining Wong, Hui Fang Lim
Publikováno v:
BMJ Open, Vol 14, Iss 6 (2024)
Objectives To evaluate asthma characteristics and treatment patterns, including short-acting β2-agonist (SABA) prescriptions, in primary and specialist care in the Singapore cohort of the SABA use IN Asthma (SABINA III) study.Design Cross-sectional,
Externí odkaz:
https://doaj.org/article/7289582929cb4fdf96e1530a08607c54
Autor:
Martti Anton Antila, Adelmir Souza-Machado, Marcelo Gervilla Gregório, Álvaro A Cruz, Luciene Angelini, Maarten J H I Beekman, Gilmar Alves Zonzin, Marcelo Fouad Rabahi
Publikováno v:
Jornal Brasileiro de Pneumologia, Vol 50, Iss 1 (2024)
ABSTRACT Objective: To assess prescription patterns for short-acting b2 agonists (SABAs) and other asthma medications in asthma patients treated by specialists and participating in the SABA use IN Asthma (SABINA) study in Brazil. Methods: This was an
Externí odkaz:
https://doaj.org/article/069434d4cd444bd094926b7c70e77733
Autor:
David Price, Kerry Hancock, Joseph Doan, Sri Wahyu Taher, Chakaya J. Muhwa, Hisham Farouk, Maarten J. H. I. Beekman
Publikováno v:
npj Primary Care Respiratory Medicine, Vol 32, Iss 1, Pp 1-10 (2022)
Abstract Short-acting β2-agonist (SABA) prescriptions and associated outcomes were assessed in 1440 patients with asthma from the SABA use IN Asthma (SABINA) III study treated in primary care. Data on asthma medications were collected, and multivari
Externí odkaz:
https://doaj.org/article/8889c35a13f14505920b73716610eebb
Autor:
Arzu Yorgancıoğlu, Kurtuluş Aksu, Sibel Atış Naycı, Dane Ediger, Dilşad Mungan, Umut Gül, Maarten J. H. I. Beekman, SABINA Turkey Study Group
Publikováno v:
BMC Pulmonary Medicine, Vol 22, Iss 1, Pp 1-13 (2022)
Abstract Background Over-reliance on short-acting β2-agonists (SABAs) is associated with poor asthma outcomes. However, the extent of SABA use in Turkey is unclear owing to a lack of comprehensive healthcare databases. Here, we describe the demograp
Externí odkaz:
https://doaj.org/article/a4d4697465d5472aaec186ce67d45843
Autor:
Adel, Khattab, Ashraf, Madkour, Anish, Ambaram, Clifford, Smith, Chakaya J, Muhwa, Jared O, Mecha, Mohamed, Alsayed, Maarten J H I, Beekman
Publikováno v:
Current medical research and opinion. 38(11)
The extent of short-acting βData on disease characteristics/asthma treatments were collected from patients (≥12 years) using electronic case report forms. Patients were classified by investigator-defined asthma severity (guided by the 2017 Global
Autor:
Felicia, Montero-Arias, Jose Carlos Herrera, Garcia, Manuel Pacheco, Gallego, Martti Anton, Antila, Patricia, Schonffeldt, Walter Javier, Mattarucco, Luis Fernando Tejado, Gallegos, Maarten J H I, Beekman
Publikováno v:
The Journal of asthma : official journal of the Association for the Care of Asthma.
Short-acting βIn this cross-sectional study, data on disease characteristics/asthma treatments were collected using electronic case report forms. Patients (aged ≥12 years) were classified by investigator-defined asthma severity (guided by the 2017
Autor:
David, Price, Kerry, Hancock, Joseph, Doan, Sri Wahyu, Taher, Chakaya J, Muhwa, Hisham, Farouk, Maarten J H I, Beekman
Publikováno v:
NPJ primary care respiratory medicine. 32(1)
Short-acting β
Autor:
Felicia Montero-Arias, Jose Carlos Herrera Garcia, Manuel Pacheco Gallego, Martti Anton Antila, Patricia Schonffeldt, Walter Javier Mattarucco, Luis Fernando Tejado Gallegos, Maarten J. H. I. Beekman
Short-acting β2-agonist (SABA) over-reliance is associated with poor asthma outcomes. As part of the SABA Use IN Asthma (SABINA) III study, we assessed SABA prescriptions and clinical outcomes in patients from six Latin American countries. In this c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2af42e1e2f59abf8db8b9bb0505e683c
Autor:
Adel Khattab, Ashraf Madkour, Anish Ambaram, Clifford Smith, Chakaya J. Muhwa, Jared O. Mecha, Mohamed Alsayed, Maarten J. H. I. Beekman
The extent of short-acting β2-agonist (SABA) overuse in Africa remains poorly documented. As part of the SABA use IN Asthma (SABINA) III study, we assessed SABA prescriptions/clinical outcomes in 3 African countries. Data on disease characteristics/
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6cf7a29644c6b6425c3ecc82c38beb19
Autor:
Arzu, Yorgancıoğlu, Kurtuluş, Aksu, Sibel Atış, Naycı, Dane, Ediger, Dilşad, Mungan, Umut, Gül, Maarten J H I, Beekman, Müge, Erbay
Publikováno v:
BMC pulmonary medicine. 22(1)
Over-reliance on short-acting βThis observational, cross-sectional study included patients aged ≥ 12 years with asthma from 24 centres across Turkey. Data on sociodemographics, disease characteristics and asthma treatments were collected using ele